Parcion Private Wealth LLC Fate Therapeutics Inc Transaction History
Parcion Private Wealth LLC
- $1.87 Billion
- Q2 2025
A detailed history of Parcion Private Wealth LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Parcion Private Wealth LLC holds 30,785 shares of FATE stock, worth $42,791. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,785
Previous 30,393
1.29%
Holding current value
$42,791
Previous $24,000
41.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding FATE
# of Institutions
150Shares Held
83.3MCall Options Held
179KPut Options Held
13.4K-
Redmile Group, LLC San Francisco, CA12.9MShares$17.9 Million1.75% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$14.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$12.2 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.54MShares$6.32 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.4MShares$4.72 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $135M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...